New CRISPR technique selectively shreds cancer cells, providing a new avenue for treating malignancies (opens in new tab)
IGI researchers used Cas12a proteins to target and destroy cells carrying a genetic mutation implicated in nearly half of all cancers. The post appeared first on .
Read the original article